1-5 of 5
Tjeerd J.F. Snijders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Plasma Extracellular Vesicle-Associated microRNAs for Early Response Prediction in Patients with High-Grade B-Cell Lymphoma

Steven Wang, Esther E.E. Drees, Cristina Gómez-Martín, A. De Jonge, Monique van Eijndhoven, Nils Groenewegen, Sandra Veldt-Verkuijlen, Marcel Nijland, Marjolein W.M. Van Der Poel, Yorick Sandberg, Rozemarijn van Rijn, Pim Mutsaers, Vibeke K.J. Vergote, Marie José Kersten, Yavuz M. Bilgin, Wendy B.C. Stevens, Marc Durian, Tjeerd J.F. Snijders, Daphne de Jong, Josée M. Zijlstra, Martine E.D. Chamuleau, Dirk Michiel Pegtel
Journal: Blood
Blood (2022) 140 (Supplement 1): 3523–3524.
https://doi.org/10.1182/blood-2022-165494
Published: 2022
Journal Articles

Effects of HLA Mismatches on Cytokine Release Syndrome and Associated Non-Relapse Mortality in Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Peter A. Von Dem Borne, Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Danielle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabo, Theo L. Nering Bögel, Mirjam A. Oudshoorn, Constantijn J.M. Halkes, Peter van Balen, Erik W.A.F. Marijt, Jennifer M.L. Tjon, Joost S.P. Vermaat, Hendrik Veelken
Journal: Blood
Blood (2022) 140 (Supplement 1): 4735–4736.
https://doi.org/10.1182/blood-2022-157012
Published: 2022
Journal Articles

Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia

Peter A. Von Dem Borne, Tjeerd J.F. Snijders, Danielle van Lammeren, Janneke Tijmensen, Erwin V. Planken, Henriette Levenga, Yascha van den Berg, Erik WAF Marijt, Peter van Balen, Jennifer M. Tjon, Joost S.P. Vermaat, Theo L. Nering Bögel, Mirjam A. Oudshoorn, Constantijn J.M. Halkes, Hendrik Veelken
Journal: Blood
Blood (2022) 140 (Supplement 1): 7742–7743.
https://doi.org/10.1182/blood-2022-157894
Published: 2022
Journal Articles

Lenalidomide-Rituximab or Lenalidomide-Rituximab-Bendamustine in Patients with Relapsed/Refractory Follicular Lymphoma: Priimary Analysis of the Randomized Phase II HOVON110/Rebel Trial

Marie José Kersten, Martin Dreyling, Kim M. Linton, Dana Chitu, Sanne Tonino, Marcel Kap, Roberto D Liu, Martine E.D. Chamuleau, Hein P.J. Visser, Eva De Jongh, Erik WAF Marijt, Maria B.L. Leijs, Yavuz M. Bilgin, Jan Dürig, Pamela McKay, Tjeerd J.F. Snijders, Andrew Pettitt, Monique C. Minnema, Gabriele Prange-Krex, Maria Cuijpers, Lara H. Böhmer, Lidwine W. Tick, Axel Florschütz, Matthijs Silbermann, Rob Fijnheer, Aart Beeker, Nelleke Tolboom, Cristina Mitea, Anne IJ Arens, Gerben JC Zwezerijnen, Wolfram Klapper, Sarah E. Coupland, Daphne de Jong, Jeanette K. Doorduijn, Josée M. Zijlstra
Journal: Blood
Blood (2022) 140 (Supplement 1): 2283–2285.
https://doi.org/10.1182/blood-2022-156085
Published: 2022
Journal Articles

A Phase I Study of Allogeneic Natural Killer Cell Therapy Generated from Cord Blood Hematopoietic Stem and Progenitor Cells in Elderly Acute Myeloid Leukemia Patients

Harry Dolstra, PhD, Mieke W.H. Roeven, MD, Jan Spanholtz, PhD, Basav Hangalapura, PhD, Marleen Tordoir, Frans Maas, Marij Leenders, Fenna Bohme, Nina Kok, Carel Trilsbeek, Jos Paardekooper, Anniek B. Van der Waart, PhD, Peter Westerweel, MD PhD, Tjeerd J.F. Snijders, MD, Gerard M.J. Bos, MD PhD, Jan J. Cornelissen, MD PhD, Hans Pruijt, MD PhD, Gerwin Huls, MD PhD, Aniek de Graaf, PhD, Bert A. van der Reijden, PhD, Nicole M.A. Blijlevens, MD PhD, Joop H. Jansen, PhD, Arnold van der Meer, PhD, Jeannette Cany, PhD, Frank Preijers, PhD, Nicolaas P.M. Schaap, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1357.
https://doi.org/10.1182/blood.V126.23.1357.1357
Published: 2015